Skip to main content
SpringerLink
Log in

Less Common Triple Negative Breast Cancers

  • Chapter
  • First Online:
Book cover A Comprehensive Guide to Core Needle Biopsies of the Breast

  • 1477 Accesses

Abstract

This chapter encompasses four uncommon types of triple negative breast cancer, which include adenoid cystic carcinoma (ACC), apocrine carcinoma, metaplastic carcinoma, and medullary carcinoma. Also included in the discussion for differential diagnosis are three additional rare subtypes: acinic cell carcinoma, oncocytic carcinoma, and mucoepidermoid carcinoma. Most of these tumors are “basal-like cancers,” as defined by gene expression analysis. Although sharing the triple negative and basal-like phenotype, these tumors demonstrate remarkably different clinical behaviors, which range along a spectrum from indolent to aggressive, emphasizing the notion that triple negative or basal-like breast cancer comprises a heterogeneous group of diseases. While ACC has well-defined histopathologic features and unique molecular alterations, metaplastic carcinomas represent a morphologically and genetically diverse group of tumors. Furthermore, uniform agreement on diagnostic criteria is lacking for medullary carcinoma and apocrine carcinoma. Accordingly, diagnosis of these uncommon lesions can be challenging, especially in core needle biopsy (CNB) specimens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM. Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer. 2002;94(8):2119–27.

    Article  PubMed  Google Scholar 

  2. Da Silva L, Buck L, Simpson PT, Reid L, McCallum N, Madigan BJ, et al. Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis. Virchows Arch. 2009;454(1):107–14.

    Article  CAS  PubMed  Google Scholar 

  3. Miyai K, Schwartz MR, Divatia MK, Anton RC, Park YW, Ayala AG, et al. Adenoid cystic carcinoma of breast: recent advances. World J Clin Cases. 2014;2(12):732–41.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Geschickter CF, editor. Diseases of the breast: diagnosis, pathology, treatment. 2nd ed. Philadelphia: JB Lippincott; 1945.

    Google Scholar 

  5. Schnitt SJ, Collins LC. Biopsy Interpretation of the Breast. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2013. p. 321–5.

    Google Scholar 

  6. Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res. 2010;12(4):R54.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ferlito ADBL. Adenoid cystic carcinoma of the male breast: report of a case. Am Surg. 1974;40:72–6.

    CAS  PubMed  Google Scholar 

  8. Hjurth SMP, Blomquist P. Adenoid cystic carcinoma of the breast: report of a case in a male and review of the literature. Acta Chir Scand. 1977;143:155–8.

    Google Scholar 

  9. McClenathan JH, de la Roza G. Adenoid cystic breast cancer. Am J Surg. 2002;183(6):646–9.

    Article  PubMed  Google Scholar 

  10. Santamaria G, Velasco M, Zanon G, Farrus B, Molina R, Sole M, et al. Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. AJR Am J Roentgenol. 1998;171(6):1679–83.

    Article  CAS  PubMed  Google Scholar 

  11. Rosen P. Adenoid cystic carcinoma of the breast. Pathol Annu. 1989;24:237–54.

    PubMed  Google Scholar 

  12. Tavassoli FA, Norris HJ. Mammary adenoid cystic carcinoma with sebaceous differentiation. A morphologic study of the cell types. Arch Pathol Lab Med. 1986;110(11):1045–53.

    CAS  PubMed  Google Scholar 

  13. Tsuboi N, Ogawa Y, Inomata T, Nishioka A, Yoshida D, Yoshida S, et al. Dynamic MR appearance of adenoid cystic carcinoma of the breast in a 67-year-old female. Radiat Med. 1998;16(3):225–8.

    CAS  PubMed  Google Scholar 

  14. Glazebrook KN, Reynolds C, Smith RL, Gimenez EI, Boughey JC. Adenoid cystic carcinoma of the breast. AJR Am J Roentgenol. 2010;194(5):1391–6.

    Article  PubMed  Google Scholar 

  15. Sheen-Chen SM, Eng HL, Chen WJ, Cheng YF, Ko SF. Adenoid cystic carcinoma of the breast: truly uncommon or easily overlooked? Anticancer Res. 2005;25(1B):455–8.

    PubMed  Google Scholar 

  16. Kasami M, Olson SJ, Simpson JF, Page DL. Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: an immunohistochemical study. Histopathology. 1998;32(3):232–8.

    Article  CAS  PubMed  Google Scholar 

  17. Shin SJ, Rosen PP. Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases. Am J Surg Pathol. 2002;26(4):413–20.

    Article  PubMed  Google Scholar 

  18. Lamovec J, Us-Krasovec M, Zidar A, Kljun A. Adenoid cystic carcinoma of the breast: a histologic, cytologic, and immunohistochemical study. Semin Diagn Pathol. 1989;6(2):153–64.

    CAS  PubMed  Google Scholar 

  19. Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol. 1987;18(12):1276–81.

    Article  CAS  PubMed  Google Scholar 

  20. Kleer CG, Oberman HA. Adenoid cystic carcinoma of the breast: value of histologic grading and proliferative activity. Am J Surg Pathol. 1998;22(5):569–75.

    Article  CAS  PubMed  Google Scholar 

  21. D’Alfonso TM, Mosquera JM, MacDonald TY, Padilla J, Liu YF, Rubin MA, et al. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features. Hum Pathol. 2014;45(11):2270–80.

    Article  PubMed  CAS  Google Scholar 

  22. Acs G, Simpson JF, Bleiweiss IJ, Hugh J, Reynolds C, Olson S, et al. Microglandular adenosis with transition into adenoid cystic carcinoma of the breast. Am J Surg Pathol. 2003;27(8):1052–60.

    Article  PubMed  Google Scholar 

  23. James BA, Cranor ML, Rosen PP. Carcinoma of the breast arising in microglandular adenosis. Am J Clin Pathol. 1993;100(5):507–13.

    Article  CAS  PubMed  Google Scholar 

  24. Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, et al. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol. 2008;32(4):544–52.

    Article  PubMed  Google Scholar 

  25. Righi A, Lenzi M, Morandi L, Flamminio F, De Biase D, Farnedi A, et al. Adenoid cystic carcinoma of the breast associated with invasive duct carcinoma: a case report. Int J Surg Pathol. 2011;19(2):230–4.

    Article  PubMed  Google Scholar 

  26. Peters GN, Wolff M. Adenoid cystic carcinoma of the breast. Report of 11 new cases: review of the literature and discussion of biological behavior. Cancer. 1982;52:680–6.

    Article  Google Scholar 

  27. Zaloudek C, Oertel YC, Orenstein JM. Adenoid cystic carcinoma of the breast. Am J Clin Pathol. 1984;81(3):297–307.

    Article  CAS  PubMed  Google Scholar 

  28. Vranic S, Bender R, Palazzo J, Gatalica Z. A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics. Hum Pathol. 2013;44(3):301–9.

    Article  CAS  PubMed  Google Scholar 

  29. Mastropasqua MG, Maiorano E, Pruneri G, Orvieto E, Mazzarol G, Vento AR, et al. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast. Mod Pathol. 2005;18(10):1277–82.

    Article  CAS  PubMed  Google Scholar 

  30. Crisi GM, Marconi SA, Makari-Judson G, Goulart RA. Expression of c-kit in adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;124(5):733–9.

    Article  CAS  PubMed  Google Scholar 

  31. Azoulay S, Lae M, Freneaux P, Merle S, Al Ghuzlan A, Chnecker C, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol. 2005;18(12):1623–31.

    CAS  PubMed  Google Scholar 

  32. Hill PA. c-kit expression in adenoid cystic carcinoma of the breast. Pathology. 2004;36(4):362–4.

    Article  CAS  PubMed  Google Scholar 

  33. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008;216(2):141–50.

    Article  CAS  PubMed  Google Scholar 

  34. Trendell-Smith NJ, Peston D, Shousha S. Adenoid cystic carcinoma of the breast: a tumour commonly devoid of oestrogen receptors and related proteins. Histopathology. 1999;35(3):241–8.

    Article  CAS  PubMed  Google Scholar 

  35. Vranic S, Gatalica Z, Deng H, Frkovic-Grazio S, Lee LM, Gurjeva O, et al. ER-alpha36, a novel isoform of ER-alpha66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast. J Clin Pathol. 2011;64(1):54–7.

    Article  PubMed  Google Scholar 

  36. Wetterskog D, Lopez-Garcia MA, Lambros MB, A’Hern R, Geyer FC, Milanezi F, et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol. 2012;226(1):84–96.

    Article  CAS  PubMed  Google Scholar 

  37. Pastolero G, Hanna W, Zbieranowski I, Kahn HJ. Proliferative activity and p53 expression in adenoid cystic carcinoma of the breast. Mod Pathol. 1996;9(3):215–9.

    CAS  PubMed  Google Scholar 

  38. Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, et al. Adenoid cystic carcinomas of the breast have low Topo IIalpha expression but frequently overexpress EGFR protein without EGFR gene amplification. Hum Pathol. 2010;41(11):1617–23.

    Article  CAS  PubMed  Google Scholar 

  39. Albores-Saavedra J, Heard SC, McLaren B, Kamino H, Witkiewicz AK. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;123(6):866–73.

    Article  PubMed  Google Scholar 

  40. Mahmoud A, Hill DH, O’Sullivan MJ, Bennett MW. Cylindroma of the breast: a case report and review of the literature. Diagn Pathol. 2009;4:30.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009;106(44):18740–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Hudson JB, Collins BT. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization. Arch Pathol Lab Med. 2014;138(3):403–9.

    Article  PubMed  Google Scholar 

  43. Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN, et al. CD44(+)/CD24(−/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Hum Pathol. 2012;43(3):364–73.

    Article  CAS  PubMed  Google Scholar 

  44. Horlings HM, Weigelt B, Anderson EM, Lambros MB, Mackay A, Natrajan R, et al. Genomic profiling of histological special types of breast cancer. Breast Cancer Res Treat. 2013;142(2):257–69.

    Article  CAS  PubMed  Google Scholar 

  45. Vranic S, Gurjeva O, Frkovic-Grazio S, Palazzo J, Tawfik O, Gatalica Z. IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast. Appl Immunohistochem Mol Morphol. 2011;19(5):413–6.

    Article  CAS  PubMed  Google Scholar 

  46. Wetterskog D, Wilkerson PM, Rodrigues DN, Lambros MB, Fritchie K, Andersson MK, et al. Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations. Histopathology. 2013;62(4):543–50.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Vranic S, Bilalovic N, Lee LM, Kruslin B, Lilleberg SL, Gatalica Z. PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney. Hum Pathol. 2007;38(9):1425–31.

    Article  CAS  PubMed  Google Scholar 

  48. Vranic S, Frkovic-Grazio S, Bilalovic N, Gatalica Z. Angiogenesis in triple-negative adenoid cystic carcinomas of the breast. Virchows Arch. 2011;459(4):377–82.

    Article  CAS  PubMed  Google Scholar 

  49. Millar BA, Kerba M, Youngson B, Lockwood GA, Liu FF. The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast. Breast Cancer Res Treat. 2004;87(3):225–32.

    Article  PubMed  Google Scholar 

  50. Page DL. Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis. Breast Cancer Res Treat. 2005;93(3):189–90.

    Article  PubMed  Google Scholar 

  51. Sumpio BE, Jennings TA, Merino MJ, Sullivan PD. Adenoid cystic carcinoma of the breast. Data from the Connecticut Tumor Registry and a review of the literature. Ann Surg. 1987;205(3):295–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Kim M, Lee DW, Im J, Suh KJ, Keam B, Moon HG, et al. Adenoid cystic carcinoma of the breast: a case series of six patients and literature review. Cancer Res Treat. 2014;46(1):93–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Hodgson NC, Lytwyn A, Bacopulos S, Elavathil L. Adenoid cystic breast carcinoma: high rates of margin positivity after breast conserving surgery. Am J Clin Oncol. 2010;33(1):28–31.

    Article  PubMed  Google Scholar 

  54. Coates JM, Martinez SR, Bold RJ, Chen SL. Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol. 2010;102(4):342–7.

    Article  PubMed  Google Scholar 

  55. Khanfir K, Kallel A, Villette S, Belkacemi Y, Vautravers C, Nguyen T, et al. Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2012;82(5):2118–24.

    Article  PubMed  Google Scholar 

  56. Allen Jr MS, Marsh Jr WL. Lymph node involvement by direct extension in adenoid cystic carcinoma. Absence of classic embolic lymph node metastasis. Cancer. 1976;38(5):2017–21.

    Article  PubMed  Google Scholar 

  57. O’Malley FP, Pinder SE, Mulligan AM, editor. Breast pathology. 2nd ed. Philadelphia: Elsevier/Saunders; 2011.

    Google Scholar 

  58. Vranic S, Tawfik O, Palazzo J, Bilalovic N, Eyzaguirre E, Lee LM, et al. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast. Mod Pathol. 2010;23(5):644–53.

    Article  CAS  PubMed  Google Scholar 

  59. Yamazaki M, Nagata Y, Monji S, Shigematsu Y, Baba T, Shimokawa H, et al. Apocrine carcinoma of the breast. J UOEH. 2011;33(4):293–301.

    PubMed  Google Scholar 

  60. Vranic S, Schmitt F, Sapino A, Costa JL, Reddy S, Castro M, et al. Apocrine carcinoma of the breast: a comprehensive review. Histol Histopathol. 2013;28(11):1393–409.

    PubMed  Google Scholar 

  61. Dellapasqua S, Maisonneuve P, Viale G, Pruneri G, Mazzarol G, Ghisini R, et al. Immunohistochemically defined subtypes and outcome of apocrine breast cancer. Clin Breast Cancer. 2013;13(2):95–102.

    Article  CAS  PubMed  Google Scholar 

  62. Mossler JA, Barton TK, Brinkhous AD, McCarty KS, Moylan JA, McCarty Jr KS. Apocrine differentiation in human mammary carcinoma. Cancer. 1980;46(11):2463–71.

    Article  CAS  PubMed  Google Scholar 

  63. Gerhard R, Costa JL, Schmitt F. Benign and malignant apocrine lesions of the breast. Expert Rev Anticancer Ther. 2012;12(2):215–21.

    Article  PubMed  Google Scholar 

  64. Lakhani SR EI, Schnitt SJ,Tan PH, Van de Vijver MJ, editor. WHO classification of tumors of the breast. 4th ed. Lyon: IARC Press; 2012.

    Google Scholar 

  65. Schmitt FC, Soares R, Seruca R. Bilateral apocrine carcinoma of the breast. Molecular and immunocytochemical evidence for two independent primary tumours. Virchows Arch. 1998;433(6):505–9.

    Article  CAS  PubMed  Google Scholar 

  66. Ogiya A, Horii R, Osako T, Ito Y, Iwase T, Eishi Y, et al. Apocrine metaplasia of breast cancer: clinicopathological features and predicting response. Breast Cancer. 2010;17(4):290–7.

    Article  PubMed  Google Scholar 

  67. Tsutsumi Y. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Jpn J Clin Oncol. 2012;42(5):375–86.

    Article  PubMed  Google Scholar 

  68. Durham JR, Fechner RE. The histologic spectrum of apocrine lesions of the breast. Am J Clin Pathol. 2000;113(5 Suppl 1):S3–18.

    CAS  PubMed  Google Scholar 

  69. Rosen P. Rosen’s breast pathology. Philadelphia: Lippincott Williams and Williams; 2014.

    Google Scholar 

  70. Hood CI, Font RL, Zimmerman LE. Metastatic mammary carcinoma in the eyelid with histiocytoid appearance. Cancer. 1973;31(4):793–800.

    Article  CAS  PubMed  Google Scholar 

  71. Eusebi V, Millis RR, Cattani MG, Bussolati G, Azzopardi JG. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study. Am J Pathol. 1986;123(3):532–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, et al. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. Histopathology. 2005;47(2):195–201.

    Article  CAS  PubMed  Google Scholar 

  73. Kasashima S, Kawashima A, Ozaki S, Nakanuma Y. Expression of 5alpha-reductase in apocrine carcinoma of the breast and its correlation with clinicopathological aggressiveness. Histopathology. 2012;60(6B):E51–7.

    Article  PubMed  Google Scholar 

  74. Tanaka K, Imoto S, Wada N, Sakemura N, Hasebe K. Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients. Breast J. 2008;14(2):164–8.

    Article  PubMed  Google Scholar 

  75. Celis JE, Cabezon T, Moreira JM, Gromov P, Gromova I, Timmermans-Wielenga V, et al. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol. 2009;3(3):220–37.

    Article  CAS  PubMed  Google Scholar 

  76. Honma N, Takubo K, Arai T, Younes M, Kasumi F, Akiyama F, et al. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast. APMIS. 2006;114(10):712–9.

    Article  CAS  PubMed  Google Scholar 

  77. Banneau G, Guedj M, MacGrogan G, de Mascarel I, Velasco V, Schiappa R, et al. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res. 2010;12(4):R63.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Gromov P, Espinoza JA, Talman ML, Honma N, Kroman N, Timmermans Wielenga V, et al. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. PLoS One. 2014;9(11):e112024.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  79. Moriya T, Sakamoto K, Sasano H, Kawanaka M, Sonoo H, Manabe T, et al. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod Pathol. 2000;13(1):13–8.

    Article  CAS  PubMed  Google Scholar 

  80. Krings G, Nystrom M, Mehdi I, Vohra P, Chen YY. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer. Hum Pathol. 2014;45(11):2225–32.

    Article  CAS  PubMed  Google Scholar 

  81. Shao MM, Chan SK, Yu AM, Lam CC, Tsang JY, Lui PC, et al. Keratin expression in breast cancers. Virchows Arch. 2012;461(3):313–22.

    Article  CAS  PubMed  Google Scholar 

  82. Shousha S, Bull TB, Southall PJ, Mazoujian G. Apocrine carcinoma of the breast containing foam cells. An electron microscopic and immunohistological study. Histopathology. 1987;11(6):611–20.

    Article  CAS  PubMed  Google Scholar 

  83. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene. 2005;24(29):4660–71.

    Article  CAS  PubMed  Google Scholar 

  84. Ragazzi M, de Biase D, Betts CM, Farnedi A, Ramadan SS, Tallini G, et al. Oncocytic carcinoma of the breast: frequency, morphology and follow-up. Hum Pathol. 2011;42(2):166–75.

    Article  PubMed  Google Scholar 

  85. Damiani S, Eusebi V, Losi L, D’Adda T, Rosai J. Oncocytic carcinoma (malignant oncocytoma) of the breast. Am J Surg Pathol. 1998;22(2):221–30.

    Article  CAS  PubMed  Google Scholar 

  86. Geyer FC, de Biase D, Lambros MB, Ragazzi M, Lopez-Garcia MA, Natrajan R, et al. Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology. Breast Cancer Res Treat. 2012;132(1):15–28.

    Article  CAS  PubMed  Google Scholar 

  87. Pia-Foschini M, Reis-Filho JS, Eusebi V, Lakhani SR. Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol. 2003;56(7):497–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Costa MJ, Silverberg SG. Oncocytic carcinoma of the male breast. Arch Pathol Lab Med. 1989;113(12):1396–9.

    CAS  PubMed  Google Scholar 

  89. Roncaroli F, Lamovec J, Zidar A, Eusebi V. Acinic cell-like carcinoma of the breast. Virchows Arch. 1996;429(1):69–74.

    Article  CAS  PubMed  Google Scholar 

  90. Limite G, Di Micco R, Esposito E, Sollazzo V, Cervotti M, Pettinato G, et al. Acinic cell carcinoma of the breast: review of the literature. Int J Surg. 2014;12 Suppl 1:S35–9.

    Article  PubMed  Google Scholar 

  91. Damiani S, Pasquinelli G, Lamovec J, Peterse JL, Eusebi V. Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study. Virchows Arch. 2000;437(1):74–81.

    Article  CAS  PubMed  Google Scholar 

  92. Foschini MP, Eusebi V. Carcinomas of the breast showing myoepithelial cell differentiation. A review of the literature. Virchows Arch. 1998;432(4):303–10.

    Article  CAS  PubMed  Google Scholar 

  93. Peintinger F, Leibl S, Reitsamer R, Moinfar F. Primary acinic cell carcinoma of the breast: a case report with long-term follow-up and review of the literature. Histopathology. 2004;45(6):645–8.

    Article  CAS  PubMed  Google Scholar 

  94. Guerini-Rocco E, Hodi Z, Piscuoglio S, Ng CK, Rakha EA, Schultheis AM, et al. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study. J Pathol. 2015.

    Google Scholar 

  95. Kahn R, Holtveg H, Nissen F, Holck S. Are acinic cell carcinoma and microglandular carcinoma of the breast related lesions? Histopathology. 2003;42(2):195–6.

    Article  CAS  PubMed  Google Scholar 

  96. Geyer FC, Lacroix-Triki M, Colombo PE, Patani N, Gauthier A, Natrajan R, et al. Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. Histopathology. 2012;60(6B):E115–30.

    Article  PubMed  Google Scholar 

  97. Yates AJ, Ahmed A. Apocrine carcinoma and apocrine metaplasia. Histopathology. 1988;13(2):228–31.

    Article  CAS  PubMed  Google Scholar 

  98. Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene. 2006;25(28):3994–4008.

    Article  CAS  PubMed  Google Scholar 

  99. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Similarities of cutaneous and breast pathology in Cowden’s Syndrome. Exp Dermatol. 1998;7(6):380–90.

    Article  CAS  PubMed  Google Scholar 

  100. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Clinical and pathological features of breast disease in Cowden’s syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol. 1998;29(1):47–53.

    Article  CAS  PubMed  Google Scholar 

  101. Jones C, Damiani S, Wells D, Chaggar R, Lakhani SR, Eusebi V. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol. 2001;158(1):207–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Bundred NJ, Walker RA, Everington D, White GK, Stewart HJ, Miller WR. Is apocrine differentiation in breast carcinoma of prognostic significance? Br J Cancer. 1990;62(1):113–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. d’Amore ES, Terrier-Lacombe MJ, Travagli JP, Friedman S, Contesso G. Invasive apocrine carcinoma of the breast: a long term follow-up study of 34 cases. Breast Cancer Res Treat. 1988;12(1):37–44.

    Article  PubMed  Google Scholar 

  104. Bedford T, Alperstein A, Nathani Y, Marx R, DeVito P. A rare presentation of triple-negative apocrine breast carcinoma with metastases. J Surg Case Rep. 2014;2014(5).

    Google Scholar 

  105. Abati AD, Kimmel M, Rosen PP. Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol. 1990;94(4):371–7.

    Article  CAS  PubMed  Google Scholar 

  106. Japaze H, Emina J, Diaz C, Schwam RJ, Gercovich N, Demonty G, et al. ‘Pure’ invasive apocrine carcinoma of the breast: a new clinicopathological entity? Breast. 2005;14(1):3–10.

    Article  CAS  PubMed  Google Scholar 

  107. Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, et al. Expression of androgen receptors in primary breast cancer. Ann Oncol. 2010;21(3):488–92.

    Article  CAS  PubMed  Google Scholar 

  108. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20(8):1319–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, et al. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res. 2000;6(3):782–9.

    CAS  PubMed  Google Scholar 

  110. Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol. 1987;11(12):918–29.

    Article  CAS  PubMed  Google Scholar 

  111. Rakha EA, Tan PH, Varga Z, Tse GM, Shaaban AM, Climent F, et al. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Br J Cancer. 2015;112(2):283–9.

    Article  CAS  PubMed  Google Scholar 

  112. Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, et al. Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol. 2007;189(6):1288–93.

    Article  PubMed  Google Scholar 

  113. Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK. Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol. 2006;59(10):1079–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 2007;14(1):166–73.

    Article  PubMed  Google Scholar 

  115. Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Moinfar F. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol. 2005;29(3):347–53.

    Article  PubMed  Google Scholar 

  116. Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Mod Pathol. 2003;16(9):893–901.

    Article  PubMed  Google Scholar 

  117. Carter MR, Hornick JL, Lester S, Fletcher CD. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 2006;30(3):300–9.

    Article  PubMed  Google Scholar 

  118. Cardoso F, Leal C, Meira A, Azevedo R, Mauricio MJ, Leal da Silva JM, et al. Squamous cell carcinoma of the breast. Breast. 2000;9(6):315–9.

    Article  CAS  PubMed  Google Scholar 

  119. Rosen PP, Ernsberger D. Low-grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma. Am J Surg Pathol. 1987;11(5):351–8.

    Article  CAS  PubMed  Google Scholar 

  120. Soo K, Tan PH. Low-grade adenosquamous carcinoma of the breast. J Clin Pathol. 2013;66(6):506–11.

    Article  CAS  PubMed  Google Scholar 

  121. Kawaguchi K, Shin SJ. Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast. Am J Surg Pathol. 2012;36(7):1009–20.

    Article  PubMed  Google Scholar 

  122. Van Hoeven KH, Drudis T, Cranor ML, Erlandson RA, Rosen PP. Low-grade adenosquamous carcinoma of the breast. A clinocopathologic study of 32 cases with ultrastructural analysis. Am J Surg Pathol. 1993;17(3):248–58.

    Article  PubMed  Google Scholar 

  123. Denley H, Pinder SE, Tan PH, Sim CS, Brown R, Barker T, et al. Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases. Histopathology. 2000;36(3):203–9.

    Article  CAS  PubMed  Google Scholar 

  124. Geyer FC, Lambros MB, Natrajan R, Mehta R, Mackay A, Savage K, et al. Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast. Mod Pathol. 2010;23(7):951–60.

    Article  CAS  PubMed  Google Scholar 

  125. Tan QT, Chuwa EW, Chew SH, Lim-Tan SK, Lim SH. Low-grade adenosquamous carcinoma of the breast: A diagnostic and clinical challenge. Int J Surg. 2015;19:22–6.

    Article  PubMed  Google Scholar 

  126. Boecker W, Stenman G, Loening T, Andersson MK, Sinn HP, Barth P, et al. Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin. Histopathology. 2014;65(1):9–23.

    Article  PubMed  Google Scholar 

  127. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast. Am J Surg Pathol. 2010;34(6):896–900.

    Article  PubMed  Google Scholar 

  128. Gobbi H, Simpson JF, Borowsky A, Jensen RA, Page DL. Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer. 1999;85(10):2170–82.

    Article  CAS  PubMed  Google Scholar 

  129. Nonnis R, Paliogiannis P, Giangrande D, Marras V, Trignano M. Low-grade fibromatosis-like spindle cell metaplastic carcinoma of the breast: a case report and literature review. Clin Breast Cancer. 2012;12(2):147–50.

    Article  PubMed  Google Scholar 

  130. Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, et al. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol. 2001;25(8):1009–16.

    Article  CAS  PubMed  Google Scholar 

  131. Rito M, Schmitt F, Pinto AE, Andre S. Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype. Virchows Arch. 2014;465(2):185–91.

    Article  CAS  PubMed  Google Scholar 

  132. Wargotz ES, Deos PH, Norris HJ. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol. 1989;20(8):732–40.

    Article  CAS  PubMed  Google Scholar 

  133. Lacroix-Triki M, Geyer FC, Lambros MB, Savage K, Ellis IO, Lee AH, et al. Beta-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast. Mod Pathol. 2010;23(11):1438–48.

    Article  CAS  PubMed  Google Scholar 

  134. Khan HN, Wyld L, Dunne B, Lee AH, Pinder SE, Evans AJ, et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol. 2003;29(7):600–3.

    Article  CAS  PubMed  Google Scholar 

  135. Gersell DJ, Katzenstein AL. Spindle cell carcinoma of the breast. A clinocopathologic and ultrastructural study. Hum Pathol. 1981;12(6):550–61.

    Article  CAS  PubMed  Google Scholar 

  136. Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol. 2003;34(10):1009–15.

    Article  CAS  PubMed  Google Scholar 

  137. Lee AH. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology. 2008;52(1):45–57.

    Article  CAS  PubMed  Google Scholar 

  138. Jo VY, Fletcher CD. p63 immunohistochemical staining is limited in soft tissue tumors. Am J Clin Pathol. 2011;136(5):762–6.

    Article  PubMed  Google Scholar 

  139. Bishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014;38(2):257–64.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Cimino-Mathews A, Sharma R, Illei PB, Vang R, Argani P. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies. Am J Surg Pathol. 2014;38(12):1689–96.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Davis WG, Hennessy B, Babiera G, Hunt K, Valero V, Buchholz TA, et al. Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. Am J Surg Pathol. 2005;29(11):1456–63.

    Article  PubMed  Google Scholar 

  142. Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol. 2005;58(7):700–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  143. Reis-Filho JS, Milanezi F, Carvalho S, Simpson PT, Steele D, Savage K, et al. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis. Breast Cancer Res. 2005;7(6):R1028–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Varma S, Shin SJ. An algorithmic approach to spindle cell lesions of the breast. Adv Anat Pathol. 2013;20(2):95–109.

    Article  PubMed  Google Scholar 

  146. Menes T, Schachter J, Morgenstern S, Fenig E, Lurie H, Gutman H. Primary squamous cell carcinoma (SqCC) of the breast. Am J Clin Oncol. 2003;26(6):571–3.

    Article  PubMed  Google Scholar 

  147. Grabowski J, Saltzstein SL, Sadler G, Blair S. Squamous cell carcinoma of the breast: a review of 177 cases. Am Surg. 2009;75(10):914–7.

    PubMed  Google Scholar 

  148. Eggers JW, Chesney TM. Squamous cell carcinoma of the breast: a clinicopathologic analysis of eight cases and review of the literature. Hum Pathol. 1984;15(6):526–31.

    Article  CAS  PubMed  Google Scholar 

  149. Stevenson JT, Graham DJ, Khiyami A, Mansour EG. Squamous cell carcinoma of the breast: a clinical approach. Ann Surg Oncol. 1996;3(4):367–74.

    Article  CAS  PubMed  Google Scholar 

  150. Behranwala KA, Nasiri N, Abdullah N, Trott PA, Gui GP. Squamous cell carcinoma of the breast: clinico-pathologic implications and outcome. Eur J Surg Oncol. 2003;29(4):386–9.

    Article  CAS  PubMed  Google Scholar 

  151. Tan YM, Yeo A, Chia KH, Wong CY. Breast abscess as the initial presentation of squamous cell carcinoma of the breast. Eur J Surg Oncol. 2002;28(1):91–3.

    Article  CAS  PubMed  Google Scholar 

  152. Gupta C, Malani AK, Weigand RT, Rangineni G. Pure primary squamous cell carcinoma of the breast: a rare presentation and clinicopathologic comparison with usual ductal carcinoma of the breast. Pathol Res Pract. 2006;202(6):465–9.

    Article  PubMed  Google Scholar 

  153. Wrightson WR, Edwards MJ, McMasters KM. Primary squamous cell carcinoma of the breast presenting as a breast abscess. Am Surg. 1999;65(12):1153–5.

    CAS  PubMed  Google Scholar 

  154. Nayak A, Wu Y, Gilcrease MZ. Primary squamous cell carcinoma of the breast: predictors of locoregional recurrence and overall survival. Am J Surg Pathol. 2013;37(6):867–73.

    Article  PubMed  Google Scholar 

  155. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer. 1990;65(2):272–6.

    Article  CAS  PubMed  Google Scholar 

  156. Eusebi V, Lamovec J, Cattani MG, Fedeli F, Millis RR. Acantholytic variant of squamous-cell carcinoma of the breast. Am J Surg Pathol. 1986;10(12):855–61.

    Article  CAS  PubMed  Google Scholar 

  157. Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, et al. Squamous cell carcinoma of the breast. J Clin Oncol. 2005;23(31):7827–35.

    Article  PubMed  Google Scholar 

  158. Patchefsky AS, Frauenhoffer CM, Krall RA, Cooper HS. Low-grade mucoepidermoid carcinoma of the breast. Arch Pathol Lab Med. 1979;103(4):196–8.

    CAS  PubMed  Google Scholar 

  159. Fisher ER, Palekar AS, Gregorio RM, Paulson JD. Mucoepidermoid and squamous cell carcinomas of breast with reference to squamous metaplasia and giant cell tumors. Am J Surg Pathol. 1983;7(1):15–27.

    Article  CAS  PubMed  Google Scholar 

  160. Di Tommaso L, Foschini MP, Ragazzini T, Magrini E, Fornelli A, Ellis IO, et al. Mucoepidermoid carcinoma of the breast. Virchows Arch. 2004;444(1):13–9.

    Article  PubMed  Google Scholar 

  161. Kovi J, Duong HD, Leffall Jr LS. High-grade mucoepidermoid carcinoma of the breast. Arch Pathol Lab Med. 1981;105(11):612–4.

    CAS  PubMed  Google Scholar 

  162. Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch. 2002;440(5):536–42.

    Article  CAS  PubMed  Google Scholar 

  163. Camelo-Piragua SI, Habib C, Kanumuri P, Lago CE, Mason HS, Otis CN. Mucoepidermoid carcinoma of the breast shares cytogenetic abnormality with mucoepidermoid carcinoma of the salivary gland: a case report with molecular analysis and review of the literature. Hum Pathol. 2009;40(6):887–92.

    Article  PubMed  Google Scholar 

  164. Reyes C, Jorda M, Gomez-Fernandez C. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers. Appl Immunohistochem Mol Morphol. 2013;21(4):283–6.

    Article  CAS  PubMed  Google Scholar 

  165. Hornychova H, Ryska A, Betlach J, Bohac R, Cizek T, Tomsova M, et al. Mucoepidermoid carcinoma of the breast. Neoplasma. 2007;54(2):168–72.

    CAS  PubMed  Google Scholar 

  166. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol. 1989;20(7):628–35.

    Article  CAS  PubMed  Google Scholar 

  167. Bhosale SJ, Kshirsagar AY, Sulhyan SR, Jagtap SV. Matrix-producing metaplastic breast carcinoma—a rare malignancy. Am J Case Rep. 2013;14:213–5.

    Article  PubMed  PubMed Central  Google Scholar 

  168. Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma. Am J Surg Pathol. 2009;33(4):534–41.

    Article  PubMed  Google Scholar 

  169. Hirose T, Honda J, Bando Y, Sasa M, Hirose Y, Nagao T, et al. A case of matrix-producing carcinoma of the breast. World J Surg Oncol. 2008;6:60.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH, Huang CS. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. J Pathol. 2004;204(2):131–9.

    Article  CAS  PubMed  Google Scholar 

  171. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010;12(5):R68.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  172. Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R, et al. Metastatic breast carcinomas display genomic and transcriptomic heterogeneity. Mod Pathol. 2015;28(3):340–51.

    Article  CAS  PubMed  Google Scholar 

  173. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 2009;69(10):4116–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  174. Noel JC, Buxant F, Engohan-Aloghe C. Low-grade adenosquamous carcinoma of the breast—a case report with a BRCA1 germline mutation. Pathol Res Pract. 2010;206(7):511–3.

    Article  PubMed  Google Scholar 

  175. Reis-Filho JS, Lakhani SR, Gobbi H, Sneige N. Metaplastic carcinoma. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO classification of tumors of the breast. 4th ed. Lyon: IARC Press; 2012. p. 48–52.

    Google Scholar 

  176. Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, et al. Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Surg Today. 2011;41(3):328–32.

    Article  CAS  PubMed  Google Scholar 

  177. Liu J, Yu Y, Sun JY, He SS, Wang X, Yin J, et al. Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast. Breast Cancer Res Treat. 2015;149(1):133–40.

    Article  CAS  PubMed  Google Scholar 

  178. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer. 1977;40(4):1365–85.

    Article  CAS  PubMed  Google Scholar 

  179. Wargotz ES, Silverberg SG. Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria. Hum Pathol. 1988;19(11):1340–6.

    Article  CAS  PubMed  Google Scholar 

  180. Pedersen L, Holck S, Schiodt T, Zedeler K, Mouridsen HT. Medullary carcinoma of the breast, prognostic importance of characteristic histopathological features evaluated in a multivariate Cox analysis. Eur J Cancer. 1994;30A(12):1792–7.

    Article  CAS  PubMed  Google Scholar 

  181. Pedersen L, Zedeler K, Holck S, Schiodt T, Mouridsen HT. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features. Br J Cancer. 1991;63(4):591–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  182. Jensen ML, Kiaer H, Andersen J, Jensen V, Melsen F. Prognostic comparison of three classifications for medullary carcinomas of the breast. Histopathology. 1997;30(6):523–32.

    Article  CAS  PubMed  Google Scholar 

  183. Pedersen L, Zedeler K, Holck S, Schiodt T, Mouridsen HT. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer. 1995;31A(13-14):2289–95.

    Article  CAS  PubMed  Google Scholar 

  184. Pedersen L, Holck S, Schiodt T, Zedeler K, Mouridsen HT. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications. Breast Cancer Res Treat. 1989;14(1):91–9.

    Article  CAS  PubMed  Google Scholar 

  185. Gaffey MJ, Mills SE, Frierson Jr HF, Zarbo RJ, Boyd JC, Simpson JF, et al. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. Mod Pathol. 1995;8(1):31–8.

    CAS  PubMed  Google Scholar 

  186. Moore Jr OS, Foote Jr FW. The relatively favorable prognosis of medullary carcinoma of the breast. Cancer. 1949;2(4):635–42.

    Article  PubMed  Google Scholar 

  187. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36(1):1–85.

    Article  CAS  PubMed  Google Scholar 

  188. Reinfuss M, Stelmach A, Mitus J, Rys J, Duda K. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J Surg Oncol. 1995;60(2):89–94.

    Article  CAS  PubMed  Google Scholar 

  189. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer. 1988;61(12):2503–10.

    Article  CAS  PubMed  Google Scholar 

  190. Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, Ohlschlegel C, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol. 2012;23(11):2843–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  191. Marginean F, Rakha EA, Ho BC, Ellis IO, Lee AH. Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Mod Pathol. 2010;23(10):1357–63.

    Article  CAS  PubMed  Google Scholar 

  192. Rubens JR, Lewandrowski KB, Kopans DB, Koerner FC, Hall DA, McCarthy KA. Medullary carcinoma of the breast. Overdiagnosis of a prognostically favorable neoplasm. Arch Surg. 1990;125(5):601–4.

    Article  CAS  PubMed  Google Scholar 

  193. Richardson WW. Medullary carcinoma of the breast; a distinctive tumour type with a relatively good prognosis following radical mastectomy. Br J Cancer. 1956;10(3):415–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  194. Bloom HJ, Richardson WW, Field JR. Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J. 1970;3(5716):181–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  195. Maier WP, Rosemond GP, Goldman LI, Kaplan GF, Tyson RR. A ten year study of medullary carcinoma of the breast. Surg Gynecol Obstet. 1977;144(5):695–8.

    CAS  PubMed  Google Scholar 

  196. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93(9):1046–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  197. Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys. 2005;62(4):1040–7.

    Article  PubMed  Google Scholar 

  198. Anderson WF, Pfeiffer RM, Dores GM, Sherman ME. Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1899–905.

    Article  PubMed  Google Scholar 

  199. Rosen PP, Lesser ML, Kinne DW. Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. J Surg Oncol. 1985;28(2):90–6.

    Article  CAS  PubMed  Google Scholar 

  200. Mittra NK, Rush Jr BF, Verner E. A comparative study of breast cancer in the black and white populations of two inner-city hospitals. J Surg Oncol. 1980;15(1):11–7.

    Article  CAS  PubMed  Google Scholar 

  201. Ownby HE, Frederick J, Russo J, Brooks SC, Swanson GM, Heppner GH, et al. Racial differences in breast cancer patients. J Natl Cancer Inst. 1985;75(1):55–60.

    CAS  PubMed  Google Scholar 

  202. Neuman ML, Homer MJ. Association of medullary carcinoma with reactive axillary adenopathy. AJR Am J Roentgenol. 1996;167(1):185–6.

    Article  CAS  PubMed  Google Scholar 

  203. Kleer CG. Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions. Arch Pathol Lab Med. 2009;133(11):1822–5.

    PubMed  Google Scholar 

  204. Meyer JE, Amin E, Lindfors KK, Lipman JC, Stomper PC, Genest D. Medullary carcinoma of the breast: mammographic and US appearance. Radiology. 1989;170(1 Pt 1):79–82.

    Article  CAS  PubMed  Google Scholar 

  205. Jeong SJ, Lim HS, Lee JS, Park MH, Yoon JH, Park JG, et al. Medullary carcinoma of the breast: MRI findings. AJR Am J Roentgenol. 2012;198(5):W482–7.

    Article  PubMed  Google Scholar 

  206. Yoo JL, Woo OH, Kim YK, Cho KR, Yong HS, Seo BK, et al. Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas? Radiographics. 2010;30(6):1689–702.

    Article  PubMed  Google Scholar 

  207. Pedersen L, Schiodt T, Holck S, Zedeler K. The prognostic importance of syncytial growth pattern in medullary carcinoma of the breast. APMIS. 1990;98(10):921–6.

    Article  CAS  PubMed  Google Scholar 

  208. Tot T. The cytokeratin profile of medullary carcinoma of the breast. Histopathology. 2000;37(2):175–81.

    Article  CAS  PubMed  Google Scholar 

  209. Larsimont D, Lespagnard L, Degeyter M, Heimann R. Medullary carcinoma of the breast: a tumour lacking keratin 19. Histopathology. 1994;24(6):549–52.

    Article  CAS  PubMed  Google Scholar 

  210. Rodriguez-Pinilla SM, Rodriguez-Gil Y, Moreno-Bueno G, Sarrio D, Martin-Guijarro Mdel C, Hernandez L, et al. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study. Am J Surg Pathol. 2007;31(4):501–8.

    Article  PubMed  Google Scholar 

  211. Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, et al. Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol. 2005;207(3):260–8.

    Article  CAS  PubMed  Google Scholar 

  212. Flucke U, Flucke MT, Hoy L, Breuer E, Goebbels R, Rhiem K, et al. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathology. 2010;56(7):852–9.

    Article  PubMed  Google Scholar 

  213. Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res. 2007;9(2):R24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  214. Chu Z, Lin H, Liang X, Huang R, Zhan Q, Jiang J, et al. Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases. PLoS One. 2014;9(11):e111493.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  215. Reiner A, Reiner G, Spona J, Schemper M, Holzner JH. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis. Cancer. 1988;61(6):1149–54.

    Article  CAS  PubMed  Google Scholar 

  216. Stierer M, Rosen H, Weber R, Hanak H, Spona J, Tuchler H. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg. 1993;218(1):13–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  217. Soomro S, Shousha S, Taylor P, Shepard HM, Feldmann M. c-erbB-2 expression in different histological types of invasive breast carcinoma. J Clin Pathol. 1991;44(3):211–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  218. Somerville JE, Clarke LA, Biggart JD. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. J Clin Pathol. 1992;45(1):16–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  219. Berglund P, Stighall M, Jirstrom K, Borgquist S, Sjolander A, Hedenfalk I, et al. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers. Cancer Res. 2005;65(21):9727–34.

    Article  CAS  PubMed  Google Scholar 

  220. de Cremoux P, Salomon AV, Liva S, Dendale R, Bouchind’homme B, Martin E, et al. p53 mutation as a genetic trait of typical medullary breast carcinoma. J Natl Cancer Inst. 1999;91(7):641–3.

    Article  PubMed  Google Scholar 

  221. Kajiwara M, Toyoshima S, Yao T, Tanaka M, Tsuneyoshi M. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry. J Surg Oncol. 1999;70(4):209–16.

    Article  CAS  PubMed  Google Scholar 

  222. Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Am J Pathol. 1993;142(3):669–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  223. Reyes C, Gomez-Fernandez C, Nadji M. Metaplastic and medullary mammary carcinomas do not express mammaglobin. Am J Clin Pathol. 2012;137(5):747–52.

    Article  PubMed  Google Scholar 

  224. Guo X, Fan Y, Lang R, Gu F, Chen L, Cui L, et al. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast. Mod Pathol. 2008;21(9):1101–7.

    Article  CAS  PubMed  Google Scholar 

  225. Kuroda H, Tamaru J, Sakamoto G, Ohnisi K, Itoyama S. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch. 2005;446(1):10–4.

    Article  PubMed  Google Scholar 

  226. Yakirevich E, Izhak OB, Rennert G, Kovacs ZG, Resnick MB. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod Pathol. 1999;12(11):1050–6.

    CAS  PubMed  Google Scholar 

  227. Dadmanesh F, Peterse JL, Sapino A, Fonelli A, Eusebi V. Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection. Histopathology. 2001;38(1):54–61.

    Article  CAS  PubMed  Google Scholar 

  228. Lespagnard L, Cochaux P, Larsimont D, Degeyter M, Velu T, Heimann R. Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am J Clin Pathol. 1995;103(4):449–52.

    Article  CAS  PubMed  Google Scholar 

  229. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst. 1999;91(16):1376–81.

    Article  CAS  PubMed  Google Scholar 

  230. Shousha S. Medullary carcinoma of the breast and BRCA1 mutation. Histopathology. 2000;37(2):182–5.

    Article  CAS  PubMed  Google Scholar 

  231. Eisinger F, Jacquemier J, Charpin C, Stoppa-Lyonnet D, Bressac-de Paillerets B, Peyrat JP, et al. Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res. 1998;58(8):1588–92.

    CAS  PubMed  Google Scholar 

  232. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 1996;77(4):697–709.

    Article  CAS  PubMed  Google Scholar 

  233. Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Lenoir GM, et al. BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat. 1997;44(3):275–7.

    Article  CAS  PubMed  Google Scholar 

  234. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000;92(7):564–9.

    Article  CAS  PubMed  Google Scholar 

  235. Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adelaide J, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006;66(9):4636–44.

    Article  CAS  PubMed  Google Scholar 

  236. Fisher ER, Kenny JP, Sass R, Dimitrov NV, Siderits RH, Fisher B. Medullary cancer of the breast revisited. Breast Cancer Res Treat. 1990;16(3):215–29.

    Article  CAS  PubMed  Google Scholar 

  237. Rakha EA, Aleskandarany M, El-Sayed ME, Blamey RW, Elston CW, Ellis IO, et al. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer. 2009;45(10):1780–7.

    Article  CAS  PubMed  Google Scholar 

  238. Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, et al. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res. 2009;11(2):R15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  239. Weiss MC, Fowble BL, Solin LJ, Yeh IT, Schultz DJ. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 1992;23(5):941–7.

    Article  CAS  PubMed  Google Scholar 

  240. Kurtz JM, Amalric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989;63(10):1912–7.

    Article  CAS  PubMed  Google Scholar 

  241. Tramm T, Kim JY, Tavassoli FA. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast. Am J Surg Pathol. 2011;35(2):202–11.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of California San Francisco (UCSF), San Francisco, CA, USA

    Poonam Vohra M.D., Gregor Krings M.D., Ph.D. & Yunn-Yi Chen M.D., Ph.D.

Authors
  1. Poonam Vohra M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregor Krings M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yunn-Yi Chen M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yunn-Yi Chen M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA

    Sandra J. Shin

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Vohra, P., Krings, G., Chen, YY. (2016). Less Common Triple Negative Breast Cancers. In: Shin, S. (eds) A Comprehensive Guide to Core Needle Biopsies of the Breast . Springer, Cham. https://doi.org/10.1007/978-3-319-26291-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26291-8_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26289-5

  • Online ISBN: 978-3-319-26291-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation